Advertisement
Letter to the Editor| Volume 11, ISSUE 5, P377-378, June 2010

Preventive Treatment With Acarbose in Diabetic Reactive Hypoglycemia

      Acarbose primarily inhibits α-glucosidase enzymes and diminishes and slows down the intestinal carbohydrate breakdown for absorption from polysaccharides to disaccharides and from disaccharides to monosaccharide.
      • Lee A.
      Management of elderly diabetic patients in the subacute care setting.
      • Mazza A.D.
      • Morley J.E.
      Update on diabetes in the elderly and the application of current therapeutics.
      Case reports and double-blinded clinical trials have shown acarbose is effective in preventing postprandial hypoglycemia in patients with reactive hypoglycemia
      • Imhof A.
      • Schneemann M.
      • Schaffner A.
      • Brundle M.
      Reactive hypoglycemia due to late dumping syndrome: Successful treatment with acarbose.
      • Speth P.A.J.
      • Jansen J.B.M.J.
      • Lamers C.B.H.W.
      Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycemia after gastric surgery.
      • Gerard J.
      • Luyckx A.S.
      • Lefebvre P.J.
      Acarbose in reactive hypoglycemia: A double-blind study.
      with most cases being after gastric surgery. Thus far, there has been only one case report
      • Imhof A.
      • Schneemann M.
      • Schaffner A.
      • Brundle M.
      Reactive hypoglycemia due to late dumping syndrome: Successful treatment with acarbose.
      published on the use of acarbose that examined the relation between GLP-1 secretion and insulin-glucose dynamics. It showed
      • Imhof A.
      • Schneemann M.
      • Schaffner A.
      • Brundle M.
      Reactive hypoglycemia due to late dumping syndrome: Successful treatment with acarbose.
      an increase in the glucose nadir when ingesting sucrose with acarbose, with postprandial glucose and insulin peaks being blunted and parallel reductions in GLP-1 responses.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee A.
        Management of elderly diabetic patients in the subacute care setting.
        Clin Geriatr Med. 2000; 16: 833-852
        • Mazza A.D.
        • Morley J.E.
        Update on diabetes in the elderly and the application of current therapeutics.
        J Am Med Dir Assoc. 2007; 8: 489-492
        • Imhof A.
        • Schneemann M.
        • Schaffner A.
        • Brundle M.
        Reactive hypoglycemia due to late dumping syndrome: Successful treatment with acarbose.
        Swiss Med Wkly. 2001; 131: 81-83
        • Speth P.A.J.
        • Jansen J.B.M.J.
        • Lamers C.B.H.W.
        Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycemia after gastric surgery.
        Gut. 1983; 24: 798-802
        • Gerard J.
        • Luyckx A.S.
        • Lefebvre P.J.
        Acarbose in reactive hypoglycemia: A double-blind study.
        Int J Clin Pharmacol Ther Toxicol. 1984; 22: 25-31
        • Góke B.
        • Fuder H.
        • Wieckhorst G.
        • et al.
        Voglibose (AO-128) is an efficient α-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve.
        Digestion. 1995; 56: 493-501
        • Seifarth C.
        • Bergmann J.
        • Nauck M.A.
        • et al.
        Prolonged and enhanced secretion of glucagon-like peptide 1 (7–36 amide) after oral sucrose due to α-glucosidase inhibition (acarbose) in type 2 diabetic patients.
        Diabet Med. 1998; 15: 485-491
        • Lee A.
        • Patrick P.
        • Wishart J.
        • et al.
        The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
        Diabetes Obes Metab. 2002; 4: 329-335